Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. - van den Bosch,F.; Kruithof,E.; Baeten,D. (Arthritis Rheum, 2002)